Back to medications
Medication monograph

apremilast

Phosphodiesterase-4 (PDE4) InhibitorsDisease Modifying Antirheumatic Drugs (DMARDs)Disease-modifying Antirheumatic AgentsPhosphodiesterase 4 InhibitorsImmunomodulatory AgentsDisease-modifying Antirheumatic DrugsSkin and Mucous Membrane Agents, Miscellaneous

Clinical reference

Product monograph

APREMILAST kitAPREMILAST tablet, film coated

Brands & formulations

Family members

OTEZLA

Marketed
30 MGORALTABLET[ "apremilast" ]
Product monograph

GLN-APREMILAST

Marketed
30 MGORALTABLET[ "apremilast" ]
Product monograph

PMS-APREMILAST

Marketed
30 MGORALTABLET[ "apremilast" ]
Product monograph

AURO-APREMILAST

Marketed
30 MGORALTABLET[ "apremilast" ]
Product monograph

MINT-APREMILAST

Marketed
30 MGORALTABLET[ "apremilast" ]
Product monograph

JAMP APREMILAST

Marketed
30 MGORALTABLET[ "apremilast" ]
Product monograph

SANDOZ APREMILAST

Marketed
30 MGORALTABLET[ "apremilast" ]
Product monograph

APO-APREMILAST

Marketed
30 MGORALTABLET[ "apremilast" ]
Product monograph

Pricing

Price information

Otezla

Amgen · 30 mg

56: $2142.84112: $3928.56

Apremilast Starter Kit (4 tabs/4 tabs/19 tabs)

Generic · 10 mg/20 mg/30 mg

27: $828.56

Apremilast (Expiry Note)

Generic · 30 mg

56: $414.27112: $827.13

Classification

Chemical class
Phosphodiesterase-4 (PDE4) Inhibitors
Clinical class
Disease Modifying Antirheumatic Drugs (DMARDs)
Banks class
Disease-modifying Antirheumatic Agents, Phosphodiesterase 4 Inhibitors
AHFS family
Immunomodulatory Agents, Disease-modifying Antirheumatic Drugs, Skin and Mucous Membrane Agents, Miscellaneous